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Objective
To evaluate the efficacy of ten novel antimicrobial 
endolysins in combatting L. monocytogenes
contamination in a miniaturized lab-scale queso fresco 
model over a 28 day shelf life. 
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Conclusion
This research suggests that P118 was the most 
successful at inhibiting the growth of L. monocytogenes in 
QF.  Although all of the cheeses were plated in duplicate, 
the accuracy for days 3 and 7 is limited due to there 
being only a single biological replicate as apposed to day 
14 which contains two. In addition, PlyP PSA is shown to 
have inhibited growth on day 3, followed by a lack of 
inhibition at days 7 and promotion of bacterial growth on 
day 14. This result may be caused by an outlier in one of 
the biological replicates on day 14 possibly indicating an 
excessive inoculation of L. monocytogenes, deficient 
amount of PlyP PSA, or user error in spiral plating. The 
differences observed among the endolysins could be 
explained by differences in their respective lytic 
spectrums.
Future Work
Further research needs to be performed to determine the 
efficacy of the proposed endolysins in QF.  Additionally, 
optimization of the endolysin concentrations should be 
determined for the most economical and industrial 
application. This may include combining endolysins to be 
used in tandem to evaluate synergy. These endolysins 
may also further lend themselves as antimicrobials to 
combat L. monocytogenes in other foods while 
maintaining quality structure and flavor.
Problem
Listeria monocytogenes is problematic for the 
manufacturing, storage, and consumption of ready-to-eat 
foods. This bacterium may cause listeriosis upon 
consumption often with deadly complications. Queso
Fresco (QF), a pasteurized Hispanic-style fresh cheese 
(HSFC), has been shown to support the growth of L. 
monocytogenes. QF is the most widely produced and 
implicated HSFC in the U.S., representing a significant 
health hazard to at risk populations such as infants, 
pregnant women, elderly, and the immunocompromised. 
Approximately 16 to 27% of all L. monocytogenes 
infections occur in pregnant women, making them 18 
times more likely to contract listeriosis, often resulting in 
lethal complications for the mother and/or child.1
Methods
1. Production of Queso Fresco
2. Application of experimental treatments
Each cheese was enumerated by 
spiral plating.
Rennet and CaCl2  were 
added to warm milk 
(35ºC).
After incubation, the curds were 
cut with sterile needle and 
cooked again. 
The milk was divided into 1 mL 
batches.
The whey was poured off of 
each curd, NaCl was added, 
and the batches were 
cooked a final time. 
The curds were inoculated with L. 
monocytogenes and 2.5 U/mg of 
each endolysin was added.
 PlyP100 showed the greatest 
percent reduction on day 3 at 
81.90%±5.87
 P118 demonstrated the 
highest percentage reduction 
at 14 days, with a 
97.28%±9.52 reduction on 
day 7 and a 95.34%±11.41
reduction on day 14.
Introduction
Listeria monocytogenes is a gram-positive foodborne 
pathogen that may form biofilms within food processing 
facilities and in domestic refrigerators. L. monocytogenes
can survive for years under refrigerated storage and high 
salt contents regardless of frequent sanitation. The FDA 
has declared L. monocytogenes a zero-tolerance 
organism—completely unfit for human consumption, that 
cannot be present, at any level, in ready-to-eat foods.2
Queso Fresco is a soft HSFC most commonly 
associated with foodborne disease outbreaks. QF is 
particularly susceptible to L. monocytogenes
contamination due to a relatively low acid content, high 
water activity, and near neutral pH. Typically, 
pasteurization is an effective process for eliminating L. 
monocytogenes from the raw ingredients prior to 
cheesemaking. However, despite advances in food 
processing technology no suitable solution for post 
processing contamination has been discovered.3
Endolysins are enzymes derived from bacteriophages 
that hydrolyze bacterial cell walls leading to bacterial cell 
death.3  Endolysins maintain their lytic activity when 
applied exogenously and have a specific lytic spectrum 
that only target bacteria within a certain genus. Unlike 
traditional antimicrobials, bacteria are incapable of 
developing antimicrobial resistance to endolysins.4 In 
addition to the aforementioned properties, endolysins are 
desirable antimicrobials since they will not inadvertently 
affect the food or consumer’s microbiome. 
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Results
Highest Percent Reduction
Lowest Percent Reduction
 P35 demonstrated the lowest 
percent reduction on day 3 at 
35.15%±5.87. 
 PlyP PSA showed the lowest 
percent reduction on both day 3 
at 8.42%±5.87, and day 14 at 
-14.78%±11.41.
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Figure 1. L.monocytogenes cell counts were determined in Queso Fresco treated with 10 different endolysins, stored 
at 4°C, after days 3, 7, and 14 . The percent reduction was calculated by comparing the resulting colonies/mL to 
the control cheese.  Days 3 & 7 were done in duplicate while day 14 results were measured in duplicate across two 
biological replicates. Results means with ± SE
